PacBio Loses Patent Fight on DNA Sequence Used to Identify Virus

March 18, 2020, 4:04 PM

Pacific Biosciences of California Inc. lost a lawsuit in which it claimed that closely held Oxford Nanopore Technologies Inc.’s DNA sequencing systems infringed four patents for the technology, which Oxford had said was used in China to understand the early spread of the new coronavirus.

  • Jurors in Wilmington, Delaware, ruled on Wednesday that the patents shouldn’t have been issued in the first place because they didn’t describe the inventions in enough detail, rendering moot their finding that Oxford had infringed three of the patents
  • PacBio had argued that Oxford sequencers including the hand-held MinION use its technology without permission ...

To read the full article log in.

Learn more about a Bloomberg Law subscription.